Matches in Nanopublications for { <http://purl.org/np/RAOBgKeDknwaUkV-tJZnH9QdUdIT9hj67pv3NwXTIUHIY#association> ?p ?o ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- association type Statement assertion.
- association label "Patients with Parkinson's disease psychosis (PDP) are often treated with an atypical antipsychotic, especially quetiapine or clozapine, but side effects, lack of sufficient efficacy, or both may motivate a switch to pimavanserin, the first medication approved for management of PDP." assertion.
- association label "Patients with Parkinson's disease psychosis (PDP) are often treated with an atypical antipsychotic, especially quetiapine or clozapine, but side effects, lack of sufficient efficacy, or both may motivate a switch to pimavanserin, the first medication approved for management of PDP." assertion.
- association object HP_0000709 assertion.
- association predicate treats assertion.
- association subject DRUGBANK:DB00363 assertion.
- association relation OffLabelIndication assertion.
- association publications 30588905 assertion.
- association provided_by NeuroDKG assertion.
- association has_population_context context assertion.